Adam S. Grossman
President and CEO at Adma Biologics · 27 reported transactions in 1 company · latest trade Feb 17, 2026
Their trades
Sold | Feb 17, 2026 | Feb 17, 2026 close $15.95 → Oct 26, 2026 close $11.06. S&P 500 +12.1% over the same days. | ||
Sold | Feb 17, 2026 | Feb 17, 2026 close $15.95 → Oct 26, 2026 close $11.06. S&P 500 +12.1% over the same days. | ||
Sold | Dec 15, 2025 | Dec 15, 2025 close $19.73 → Oct 26, 2026 close $11.06. S&P 500 +12.4% over the same days. | ||
Sold | Dec 15, 2025 | Dec 15, 2025 close $19.73 → Oct 26, 2026 close $11.06. S&P 500 +12.4% over the same days. | ||
Sold | Nov 19, 2025 | Nov 19, 2025 close $15.95 → Oct 26, 2026 close $11.06. S&P 500 +15.5% over the same days. |
SoldAdma Biologics
$96.5K
Feb 17, 2026 close $15.95 → Oct 26, 2026 close $11.06. S&P 500 +12.1% over the same days.
SoldAdma Biologics
$241.2K
Feb 17, 2026 close $15.95 → Oct 26, 2026 close $11.06. S&P 500 +12.1% over the same days.
SoldAdma Biologics
$118.7K
Dec 15, 2025 close $19.73 → Oct 26, 2026 close $11.06. S&P 500 +12.4% over the same days.
SoldAdma Biologics
$296.9K
Dec 15, 2025 close $19.73 → Oct 26, 2026 close $11.06. S&P 500 +12.4% over the same days.
SoldAdma Biologics
$96K
Nov 19, 2025 close $15.95 → Oct 26, 2026 close $11.06. S&P 500 +15.5% over the same days.